CVB vs PAR

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CVB

CURVEBEAM FPO [CVB]

49LOW

PAR

PARA BIO FPO [PAR]

49LOW

Score Breakdown

CVB PAR
Technical
48
68
Catalyst
52
67
Sentiment
50
50
Fundamental
52
48
Momentum
49
52
Risk Gate
37
50

Key Metrics

CVB Metric PAR
$22.0MMarket Cap$113.5M
375KAvg Volume (20d)910K
+0.2%Short Interest+0.4%
$0.17552-Week High$0.480
$0.04552-Week Low$0.240
+6.5%Daily Change+2.8%
$0.049Entry Price$0.257
-41.8%ROE-180.2%
-133.1%Profit MarginN/A

Active Signals

CVB Signals

●RSI is looking oversold — historically a spot where stocks tend to bounce
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 5.8% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (1.8x)
●Piotroski F-Score weak (2/9, low-confidence approx)

PAR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is picking up steam
●Stochastic just turned bullish from a low level — early reversal sign
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Below the 200-day average — the long-term trend is still working against it
●Low cash runway (2 quarters) - dilution risk
●Very high P/S ratio (13426.2x)
●Strong revenue growth (+51%)

Ask Scout AI to compare CVB and PAR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CVB Full Analysis → PAR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).